Umeå University's logo

umu.sePublications
Change search
Link to record
Permanent link

Direct link
Mannchen, Julie K.
Publications (2 of 2) Show all publications
Lieber, I., Van Der Feltz-Cornelis, C. M., Razvi, S., Moriarty, A. S., Wilkes, S., Ott, M., . . . Werneke, U. (2023). Treating subclinical hypothyroidism in individuals with or without mental health problems – a Delphi based expert consensus study in two countries. Frontiers in Endocrinology, Article ID 1204842.
Open this publication in new window or tab >>Treating subclinical hypothyroidism in individuals with or without mental health problems – a Delphi based expert consensus study in two countries
Show others...
2023 (English)In: Frontiers in Endocrinology, E-ISSN 1664-2392, article id 1204842Article in journal (Refereed) Published
Abstract [en]

Background: Subclinical hypothyroidism (SCH) is a common endocrine problem with prevalence estimates between 4% and 20%. Symptoms are often non-specific but can substantially affect well-being leading to repeated medical consultations. The effect of thyroid hormone replacement therapy (THRT) in patients with SCH remains uncertain. Current guidelines, limited by the lack of high-quality evidence, have been controversial with limited adherence in clinical practice.

Methods: Three-round modified Delphi method to establish consensus regarding diagnosis and treatment of individuals with SCH with and without affective disorder or anxiety, conducted with clinicians from three specialties, general practice, endocrinology and psychiatry, and two countries, Sweden and the United Kingdom.

Results: Sixty clinicians, 20 per specialty, were recruited. Fifty-three (88%) participants completed all three rounds. The participants reached consensus on five of the 26 practice statements that (a) repeated testing was required for the diagnosis of subclinical hypothyroidism, (b) antibody screening should usually occur, and (c and d) antibody screening would strengthen the indication for thyroid hormone replacement therapy in both individuals with or without affective disorder or anxiety. The participants disagreed with (e) a requirement of a TSH threshold ≥ 20 mIU/L for thyroid hormone replacement therapy start. Psychiatrists and GPs but not endocrinologists, agreed that there was a frequent discrepancy between laboratory results and clinical symptoms, and disagreed that testing for thyroid dysfunction was overused in patients presenting with depression or anxiety, or fatigue.

Conclusions: In many aspects, attitudes toward diagnosing and treating SCH remain diverse. The inability of our Delphi panel to achieve consensus on most items and the disagreement with a TSH ≥ 20 mIU/L threshold for treatment suggest that the concept of SCH may need rethinking with a better understanding of the hypothalamic-pituitary-thyroid physiology. Given that the scientific evidence is currently not conclusive, guidelines in this area should not be taken as definitive.

Place, publisher, year, edition, pages
Frontiers Media S.A., 2023
Keywords
subclinical hypothyroidism, TSH, affective disorder, Delphi method, consensus, practice guideline, thyroxine, diagnosis
National Category
Psychiatry
Identifiers
urn:nbn:se:umu:diva-203908 (URN)10.3389/fendo.2023.1204842 (DOI)001035764500001 ()37501790 (PubMedID)2-s2.0-85165991855 (Scopus ID)
Funder
Visare Norr, VISARENORR968201Norrbotten County Council, NLL-969485
Note

Originally included in thesis in manuscript form.

Available from: 2023-01-23 Created: 2023-01-23 Last updated: 2024-01-17Bibliographically approved
Ott, M., Mannchen, J. K. & Werneke, U. (2022). Comment on the serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes [Letter to the editor]. Clinical Toxicology, 60(9), 1079-1081
Open this publication in new window or tab >>Comment on the serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes
2022 (English)In: Clinical Toxicology, ISSN 1556-3650, E-ISSN 1556-9519, Vol. 60, no 9, p. 1079-1081Article in journal, Letter (Other academic) Published
Place, publisher, year, edition, pages
Taylor & Francis Group, 2022
National Category
Pharmacology and Toxicology
Identifiers
urn:nbn:se:umu:diva-200455 (URN)10.1080/15563650.2022.2101471 (DOI)000834918500001 ()35913468 (PubMedID)2-s2.0-85139535817 (Scopus ID)
Available from: 2022-10-25 Created: 2022-10-25 Last updated: 2023-03-24Bibliographically approved
Organisations

Search in DiVA

Show all publications